Magnitude of the Potential Screening Gap for Fabry Disease in Manitoba: A Population-Based Retrospective Cohort Study
Background: Fabry disease is a rare disorder caused by the deficient activity of α-galactosidase A (GLA) that often leads to organ damage. Fabry disease can be treated with enzyme replacement or pharmacological therapy, but due to its rarity and nonspecific manifestations, it often goes undiagnosed....
Gardado en:
| Principais autores: | , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
SAGE Publishing
2023-03-01
|
| Series: | Canadian Journal of Kidney Health and Disease |
| Acceso en liña: | https://doi.org/10.1177/20543581231162218 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|